Dr. Sherine Gabriel is a distinguished Egyptian-Canadian rheumatologist and visionary academic leader with extensive experience in medical education and research administration. She currently serves as the Executive Vice President of ASU Health and University Professor of the Future of Health Outcomes and Medicine at Arizona State University, overseeing a comprehensive health enterprise focused on innovation and equity. Previously, she served as the fourth president of Rush University in Chicago, becoming only the second woman to lead a major academic medical center in the United States. Prior to her presidency at Rush, Dr. Gabriel was the first female dean of Rutgers Robert Wood Johnson Medical School, where she also held the position of CEO of the Robert Wood Johnson Medical Group. Her medical training began with a Doctor of Medicine degree earned with distinction from the University of Saskatchewan, followed by internal medicine residency and rheumatology fellowship at Mayo Graduate School of Medicine, and a master's degree in clinical epidemiology from McMaster University.
Dr. Gabriel's groundbreaking research has significantly advanced the understanding of rheumatic diseases through rigorous epidemiological studies that have resulted in over 250 peer-reviewed publications, primarily funded by the National Institutes of Health. She is particularly recognized for her seminal work examining the risks of connective tissue diseases among women with breast implants, comprehensive population-based studies characterizing the epidemiology of major rheumatic diseases, and pioneering investigations into the economic impact of rheumatoid arthritis. Her research has increasingly focused on the critical intersection between rheumatoid arthritis and cardiovascular disease, revealing important connections that have informed clinical practice and improved patient outcomes. As a past president of the American College of Rheumatology, Dr. Gabriel has established herself as a leading authority who bridges clinical practice, population science, and health economics to address complex challenges in autoimmune disorders. Her methodological rigor and commitment to translating research into practical applications have made her work highly influential across the medical community.
Beyond her research contributions, Dr. Gabriel has been instrumental in transforming medical education through innovative models that prepare future physicians to deliver better care, healthier communities, and more affordable healthcare systems. Her leadership in academic medicine has been widely recognized, including election to the National Academy of Medicine in 2020 for her exceptional contributions as an inspiring thought leader in research, clinical business development and educational innovation. Dr. Gabriel has consistently championed diversity and inclusion in medicine, receiving the National Medical Fellowships' Excellence in Medical Education Award for her support of underrepresented minority students in healthcare professions. Currently at Arizona State University, she continues to drive forward-thinking initiatives that integrate education, research, and clinical practice to advance health equity and improve healthcare delivery systems. Her strategic vision for the future of health outcomes positions her at the forefront of reimagining academic health systems for the 21st century.
